| Literature DB >> 26170884 |
Marcy McCall1, Melanie McDonald2, Sally Thorne3, Alison Ward4, Carl Heneghan4.
Abstract
An increase in patient-led uptake of complementary therapies in adult cancer has led to a need for more rigorous study of such interventions and their outcomes. This study therefore aimed to evaluate the feasibility and acceptability of a yoga intervention in men and women receiving conventional treatment for a cancer diagnosis. Prospective, mixed methods feasibility trial allocated participants to receive one of three yoga interventions over a four-week study period. Data collection was completed through online survey of QOL-CA/CS and customized surveys. Fifteen participants were included (11 female) undergoing treatment for breast, prostate, colorectal, brain, and blood and lung cancer. Two participants dropped out and complete qualitative and quantitative data sets were collected from 12 participants and four yoga instructors. Other outcome measures included implementation costs patient-reported preferences for yoga intervention and changes in QOL-CA/CS. Three types of yoga intervention were safely administered in adult cancer. Mixed methods, cost-efficiency, QOL-CA/CS, and evidence-based design of yoga intervention have been used to establish feasibility and patient-preferences for yoga delivery in adult caner. Results suggest that, with some methodological improvements, a large-scale randomized controlled trial is warranted to test the efficacy of yoga for male and female cancer patients. This trial is registered with Clinicaltrials.gov NCT02309112.Entities:
Year: 2015 PMID: 26170884 PMCID: PMC4480934 DOI: 10.1155/2015/816820
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
PaT plot of yoga intervention.
| Timeline | Yoga intervention A | Yoga intervention B | Yoga intervention C |
|---|---|---|---|
| Randomisation | |||
|
| |||
| Baseline |
|
|
|
|
| |||
| Week 1 |
|
|
|
|
| |||
| Weeks 2 to 4 |
|
| |
|
| |||
| Week 5 | |||
|
| |||
| End of study |
|
|
|
|
| |||
|
| QOL-CA questionnaire completed by consenting participants (online or paper) | ||
|
| |||
|
| Semi-structured, self-reported survey (Y-ACT) to elicit information regarding at-home yoga adherence, patient experiences, utility/dysutility of yoga, patient attitude and barriers to practising yoga (online or paper) | ||
|
| |||
|
| 30-minute training session of pranayama (breathing techniques) administered by a certified yoga instructor in a group setting, given own yoga mat and book to encourage home-based practice, social gathering and tea offered to encourage group discussion | ||
|
| |||
|
| 15-minute orientation and education session delivered by a certified yoga instructor, includes identification and list of community-based and online options to practise yoga | ||
|
| |||
|
| 30-minute of asana training with 15-minute orientation of free and unlimited access to online yoga classes ( | ||
|
| |||
|
| 120-minute yoga workshop administered by a certified yoga instructor in a group setting, orientation and education session to include pranayama, dhyana, asana (physical postures), social gathering and tea offered to encourage group discussion | ||
|
| |||
|
| 3 × 60-minute yoga classes (per week) including pranayama, asana and dhyana administered by a certified yoga instructor in a group setting, social gathering and tea offered to encourage group discussion | ||
Yoga Intervention Descriptions.
| Session number | Section title | Duration | Key components | Lesson plan outline (i.e., how many minutes of what component?) |
|
| ||||
|
| ||||
|
| ||||
| 1 | Introduction to yoga | 15 min | What is yoga? How and why practice yoga? Discuss resources and how to access community-based or affordable yoga | What is Yoga? Connection of mind and body, with others and your environment; awareness. |
|
| ||||
| 1 | Yoga training | 30 min | Pranayama techniques; Satsang | 4 minutes: introduction and overview of class direction, check-in with students (either individually or collectively) |
|
| ||||
|
| ||||
|
| ||||
| 1 | Introduction to yoga and online membership | 15 min | What is yoga? How and why practice yoga? Introduce membership to | Similar to Group A, with addition of online yoga orientation |
|
| ||||
| 1 | Yoga training | 30 min | Pranayama techniques | Same as low-dose (see above) |
|
| ||||
| 1 | Yoga training | 30 min | Asana practice and safety training | All very gentle asana |
|
| ||||
| 2 | Yoga workshop | 120 min | Pranayama, asana, and dhyana techniques | 10 minutes: welcome, check-in |
|
| ||||
|
| ||||
|
| ||||
| 1 | Introduction to yoga and online membership | 15 min | What is yoga? How and why practice yoga? Introduce membership to | Same as medium-dose (see above) |
|
| ||||
| 1 | Yoga training | 30 min | Pranayama techniques; Satsang | Same as low- and medium-dose (see above) |
|
| ||||
| 1 | Yoga training | 30 min | Asana practice and safety training | Same as medium-dose (see above) |
|
| ||||
| 2 to 12 | Yoga training | 60 min | Pranayama, asana, and dhyana techniques; Satsang | 3 minutes: welcome, check-in |
Figure 1Participant flow diagram.
Participant characteristics.
| Participant | Age at consent | Gender | Tumour location | Stage of cancer | Conventional treatment status | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | I | II | III | IV | n.r | Chemotherapy | Radiotherapy | Hormone therapy | Active surveillance | After surgery | |||
| A1 | 66 | 1 | Tongue | 1 | 1 | 1 | ||||||||
| A2 | 60 | 1 | Breast | 1 | 1 | 1 | ||||||||
| A3 | 51 | 1 | Breast | 1 | 1 | 1 | 1 | |||||||
| A4 | 40 | 1 | Breast | 1 | 1 | |||||||||
| A5 | 41 | 1 | Colorectal-lung | 1 | 1 | |||||||||
|
| ||||||||||||||
| Group A total | 1 | 4 | 2 | 2 | 1 | 0 | 0 | 3 | 3 | 2 | 1 | 0 | ||
| Average | 51.6 | |||||||||||||
|
| ||||||||||||||
| B1 | 72 | 1 | Prostate | 1 | 1 | 1 | ||||||||
| B2 | 61 | 1 | Abdomen | 1 | 1 | 1 | 1 | |||||||
| B3 | 43 | 1 | Breast | 1 | 1 | 1 | ||||||||
| B4 | 51 | 1 | Colorectal | 1 | 1 | 1 | ||||||||
| B5 | 59 | 1 | Skin (forearm) | 1 | 1 | |||||||||
|
| ||||||||||||||
| Group B total | 1 | 4 | 1 | 0 | 2 | 1 | 1 | 2 | 3 | 2 | 2 | 1 | ||
| Average | 57.2 | |||||||||||||
|
| ||||||||||||||
| C1 | 57 | 1 | Prostate | 1 | 1 | |||||||||
| C2 | 52 | 1 | Breast | 1 | 1 | 1 | 1 | |||||||
| C3 | 33 | 1 | Brain | 1 | 1 | 1 | ||||||||
| C4 | 45 | 1 | Breast | 1 | 1 | 1 | ||||||||
| C5 | 38 | 1 | Blood | 1 | ||||||||||
|
| ||||||||||||||
| Group C total | 2 | 3 | 1 | 1 | 2 | 0 | 1 | 2 | 2 | 1 | 2 | 1 | ||
| Average | 45 | |||||||||||||
|
| ||||||||||||||
| Overall |
|
|
|
|
|
|
|
|
|
|
|
| ||
| Average |
| |||||||||||||
n.r: not reported.
Result of participant-reported attendance, satisfaction, and yoga utility.
| Participant | Number of | Number of online | Amount of satisfaction participating in yoga | Amount of satisfaction doing yoga with teacher | Amount of satisfaction using | Felt not being | Would prefer more online | Right amount of | Too much yoga | Utility of yoga | Disutility of yoga |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A1 | 1 | 0 | 8 | 7 | — | 8 | 5 | ||||
| A3 | 6 | 4 | 8 | 8 | 8 | 1 | 8 | 0 | |||
| A4 | 1 | 0 | 1 | 1 | 5 | 1 | 8 | 0 | |||
| A5 | 8 | 6 | 10 | 10 | 9 | 1 | 10 | 2 | |||
|
| |||||||||||
| Average |
|
|
|
|
|
|
| ||||
| Group total |
|
|
|
| |||||||
|
| |||||||||||
| B1 | 4 | 0 | 8 | 9 | 0 | 1 | 8 | 0 | |||
| B2 | 2 | 0 | 7 | 9 | 5 | 1 | 7 | 2 | |||
| B3 | 10 | 0 | 5 | 10 | 0 | 1 | 8 | 4 | |||
| B5 | 4 | 0 | 8 | 8 | — | 1 | 6 | 1 | |||
|
| |||||||||||
| Average |
|
|
|
|
|
|
| ||||
| Group total |
|
|
|
| |||||||
|
| |||||||||||
| C1 | 10 | 0 | 9 | 9 | — | 1 | 8 | 0 | |||
| C2 | 24 | 0 | 10 | 10 | — | 1 | 10 | 7 | |||
| C3 | 5 | 0 | 6 | 7 | 7 | 1 | 8 | 2 | |||
| C4 | 12 | 0 | 9 | 9 | 0 | 1 | 10 | 0 | |||
|
| |||||||||||
| Average |
|
|
|
|
|
|
| ||||
| Group total |
|
|
| ||||||||
—: not reported.
Summary of QOL-CA/CS results.
| Participants | QOL-CA/CS | QOL-CA/CS | Change in Results | Mean Difference | Approaching Clinical Significance | Incomplete Data | |
|---|---|---|---|---|---|---|---|
| Baseline | Post-Intervention | Improve | Decline | ||||
| A1 | 6.1 | 7.0 | • | 1.0 | • | ||
| A2 | 5.8 | — | — | • | |||
| A3 | 4.2 | 4.4 | • | 0.2 | |||
| A4 | 3.5 | 2.8 | • | −0.8 | • | ||
| A5 | 5.8 | 8.0 | • | 2.2 | • | ||
|
| |||||||
| Group A Average (SD) | 4.9 (1.2) | 5.5 (2.4) | 0.7 (1.3) | ||||
| 95% CI | 2.9 to 6.8 | 1.7 to 9.4 | −1.4 to 2.7 | ||||
|
| |||||||
| B1 | 7.9 | 7.3 | • | −0.7 | |||
| B2 | 5.9 | 7.0 | • | 1.1 | • | ||
| B3 | 5.1 | 4.7 | • | −0.4 | |||
| B4 | 4.2 | — | — | • | |||
| B5 | 5.6 | 5.3 | • | −0.3 | |||
|
| |||||||
| Group B Average (SD) | 6.1 (1.2) | 6.1 (1.2) | −0.1 (0.8) | ||||
| 95% CI | 4.2 to 8.1 | 4.1 to 8.0 | −1.4 to 1.1 | ||||
|
| |||||||
| C1 | 6.8 | 6.6 | • | −0.2 | |||
| C2 | 3.8 | 4.6 | • | 0.9 | • | ||
| C3 | 6.9 | 7.1 | • | 0.3 | |||
| C4 | 4.0 | 3.8 | • | −0.2 | |||
| C5 | 4.1 | — | • | ||||
|
| |||||||
| Group C Average (SD) | 5.4 (1.7) | 5.5 (1.6) | 0.2 (0.5) | ||||
| 95% CI | 2.7 to 8.1 | 3.0 to 8.6 | −0.7 to 1.0 | ||||
|
| |||||||
| Overall Average (SD) | 5.5 (1.4) | 5.7 (1.7) | 035 (0.9) | ||||
| 95% CI | 4.6 to 6.3 | 4.7 to 6.8 | −0.3 to 0.8 | ||||
| Total | 6 | 6 | 3 | ||||
The minimum clinical difference (MCID) score was not provided by instrument authors; based on a literature of similar scales of HRQoL, approaching clinical significance is defined here as mean difference >0.8; SD = standard deviation; CI = confidence interval; overall and group analysis of complete data sets only (n = 12; n = 4 per group).
Summary of QOL-CA/CS subscale results.
| Physical Wellbeing Subscale | Psychological Wellbeing Subscale | ||||||
|---|---|---|---|---|---|---|---|
| Participants | Baseline | Post-intervention | Mean Difference | Participants | Baseline | Post-intervention | Mean Difference |
| Group A | Group A | ||||||
| Average (SD) | 5.82 (1.27) | 5.19 (3.05) | −0.63 (2.66) | Average (SD) | 4.85 (1.71) | 5.73 (2.18) | 0.88 (1.09) |
| 95% CI | 3.80 to 7.84 | 0.34 to 9.77 | −3.60 to 4.86 | 95% CI | 2.13 to 7.57 | 2.24 to 9.19 | −2.61 to 0.85 |
| Group B | Group B | ||||||
| Average (SD) | 7.21 (2.25) | 7.88 (1.76) | 0.67 (0.78) | Average (SD) | 5.97 (1.20) | 5.51 (1.08) | −0.47 (0.96) |
| 95% CI | 3.64 to 10.78 | 5.08 to 10.68 | −0.57 to 1.91 | 95% CI | 4.07 to 7.87 | 3.79 to 7.23 | −2.00 to 1.06 |
| Group C | Group C | ||||||
| Average (SD) | 7.32 (2.59) | 6.60 (2.81) | −0.72 (1.54) | Average (SD) | 4.44 (1.74) | 4.89 (1.29) | 0.45 (0.45) |
| 95% CI | 3.20 to 11.44 | 2.13 to 11.07 | −3.18 to 1.74 | 95% CI | 1.67 to 7.21 | −1.56 to 2.54 | −0.27 to 1.17 |
|
| |||||||
| Overall | Overall | ||||||
| Average (SD) | 6.78 (2.04) | 6.55 (2.59) | −0.23 (1.76) | Average (SD) | 5.09 (1.57) | 5.37 (1.48) | 0.29 (0.99) |
| 95% CI | 5.49 to 8.07 | 4.90 to 8.20 | −1.35 to 0.89 | 95% CI | 4.09 to 6.09 | 4.43 to 6.31 | −0.34 to 0.92 |
|
| |||||||
| Social Wellbeing Subscale | Spiritual Wellbeing Subscale | ||||||
| Participants | Baseline | Post-intervention | Mean Difference | Participants | Baseline | Post-intervention | Mean Difference |
|
| |||||||
| Group A | Group A | ||||||
| Average (SD) | 4.94 (1.34) | 5.29 (2.74) | 0.35 (1.63) | Average (SD) | 3.82 (1.18) | 5.78 (1.97) | 1.96 (1.15) |
| 95% CI | 2.80 to 7.08 | 0.93 to 9.65 | −2.24 to 2.94 | 95% CI | 1.94 to 5.70 | 2.65 to 8.91 | 0.13 to 3.79 |
| Group B | Group B | ||||||
| Average (SD) | 6.29 (1.85) | 6.47 (1.92) | 0.19 (1.02) | Average (SD) | 5.14 (1.35) | 5.07 (1.56) | −.07 (1.74) |
| 95% CI | 3.35 to 9.23 | 3.42 to 9.52 | −1.43 to 1.81 | 95% CI | 3.00 to 7.28 | 2.59 to 7.55 | −2.70 to 2.84 |
| Group C | Group C | ||||||
| Average (SD) | 5.07 (2.06) | 4.86 (1.86) | −0.21 (0.78) | Average (SD) | 5.86 (1.62) | 6.68 (1.78) | 0.83 (0.55) |
| 95% CI | 1.79 to 8.35 | 1.90 to 7.82 | −1.45 to 1.03 | 95% CI | 3.28 to 8.44 | 3.85 to 9.51 | −0.05 to 1.66 |
|
| |||||||
| Overall | Overall | ||||||
| Average (SD) | 5.43 (1.73) | 5.54 (2.13) | 0.11 (1.11) | Average (SD) | 5.18 (1.68) | 5.85 (1.75) | 0.67 (1.63) |
| 95% CI | 4.43 to 6.53 | 4.19 to 6.89 | −0.59 to 0.81 | 95% CI | 4.11 to 6.25 | 4.74 to 6.96 | −0.42 to 1.70 |
SD = standard deviation; CI = confidence interval; complete data sets only (n = 12); subgroups (n = 4).